the German Sarcoidosis Association and the World Sarcoidosis Person of the Year Award from the Irish Sarcoidosis Charity. Bruno Crestani Bruno Crestani is Head of the Pneumology Department at the Bichat Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) in Paris (France). He is also a Professor of Pneumology at the Paris Diderot University School of Medicine (Paris, France). He is Director of the Lung Inflammation and Fibrosis research unit in INSERM 1152. In recent years, his team has focused on elucidating the pathophysiological mechanisms of IPF, including genetics. Bruno Crestani is a founding member of the European IPF Network (eurIPFnet) and Head of the Fibrosis, Inflammation and REmodelling (DHU FIRE) university department at the Paris Diderot University School of Medicine. He is also an Associate Editor of the European Respiratory Journal. Athol U. Wells Athol U. Wells is a Professor of Respiratory Medicine, Senior Consultant and the Academic Lead of the Interstitial Lung Diseases Unit at the Royal Brompton Hospital (London, UK). He completed his undergraduate training at Otago University (Dunedin, New Zealand) where he was later awarded his MD with distinction. He trained as a post-graduate and later practised as a respiratory physician in New Zealand. From 1989 to 1994, he was a research fellow at the Royal Brompton Hospital. After returning to New Zealand for 5 years, he took up his current post at Royal Brompton Hospital in 1999. Athol Wells has research interests in clinical and translational science with the unifying theme being studies of CT and PFT, both in staging disease and in the examination of disease behaviour (for clinical purposes and in studies of pathogenesis). He was a chair of the British Thoracic Society guidelines (BTS) for ILD, a co-chair in the recent (2013) American Thoracic Society (ATS)/European Respiratory Society (ERS) update of the classification of the IIPs, and a participant in a number of ATS/ ERS expert groups. He created and developed the Disease Behaviour Classification, which was endorsed in the 2013 classification of the IIPs. He is the author/co-author of over 230 peer reviewed articles and over 100 editorials, chapters and review articles. He currently serves on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. viii
Previous Page Next Page